RSL1D1 Activators
RSL1D1 activators belong to a distinct chemical class of compounds that have garnered significant attention in the realm of molecular biology and cellular research. These compounds are characterized by their unique ability to modulate the activity of RSL1D1, a protein of critical importance in various cellular processes. RSL1D1, also known as ribosomal L1 domain-containing protein 1, is a multifunctional protein found in eukaryotic cells. It plays a pivotal role in ribosome biogenesis, a fundamental process in which ribosomal RNA (rRNA) and ribosomal proteins come together to form the ribosome, the cellular machinery responsible for protein synthesis.
RSL1D1 activators are chemical agents specifically designed to enhance the function or expression of RSL1D1 within the cell. By targeting this protein, these activators can influence ribosome biogenesis and, consequently, protein synthesis. This modulation can have profound effects on various cellular processes, as protein synthesis is a fundamental aspect of cell growth, proliferation, and maintenance. Researchers have been keenly interested in studying RSL1D1 activators to unravel the intricacies of ribosome biogenesis and understand their broader implications in cellular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
This antimetabolite interferes with nucleotide synthesis, indirectly activating ribosome-related pathways by disrupting the availability of nucleotides essential for rRNA production and ribosome assembly, which could increase RSL1D1 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin directly inhibits the mTOR pathway, a regulator of protein synthesis and cell growth. By dampening mTOR activity, it can reduce ribosomal activity and indirectly activating RSL1D1-related pathways, potentially increasing RSL1D1 itself. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $131.00 $651.00 | 7 | |
everolimus is an mTOR inhibitor . It can indirectly modulate RSL1D1-related pathways by inhibiting mTOR-dependent protein synthesis, potentially increasing RSL1D1 activity. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMP-activated protein kinase (AMPK), which can indirectly activate ribosome-related pathways. Activation of AMPK may lead to changes in energy balance and protein synthesis, which could have downstream positive effects on RSL1D1 activity. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMPK, indirectly affecting ribosome-related pathways. By modulating cellular energy metabolism and protein synthesis, it can potentially increase RSL1D1 activity. | ||||||
L-Leucine | 61-90-5 | sc-364173 sc-364173A | 25 g 100 g | $21.00 $62.00 | ||
Leucine is an essential amino acid that directly activates the mTOR pathway. It promotes protein synthesis, including ribosomal proteins, indirectly enhancing RSL1D1-related pathways by potentially increasing RSL1D1 activity. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin is a hormone that stimulates cell growth and protein synthesis. It can increase/activate ribosome-related pathways by directly affecting the mTOR and other signaling pathways involved in protein synthesis, potentially increasing RSL1D1 activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat is an HDAC inhibitor used in cancer therapy. It can indirectly activate RSL1D1-related pathways by altering chromatin structure and gene expression, which may have downstream positive effects on RSL1D1 activity. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $245.00 | ||
CX-5461 inhibits RNA polymerase I, responsible for transcribing rRNA. By disrupting rRNA synthesis, it can indirectly impact ribosome biogenesis and RSL1D1-related pathways, potentially increasing RSL1D1 activity. | ||||||